Visual Universitätsmedizin Mainz

Institut für Molekulare Medizin Mainz

AG Hövelmeyer


Our research group is focused to study molecular alterations driving the development of lymphoma/leukemia as well as B-cell subset differentiation using loss and gain of function approaches in the mouse. In particular we want to understand how different signalling pathways, such as NF-κB and PI3K/AKT signalling contribute to B-cell differentiation and cancer development/progression. In line with this, we are focusing on different ubiquitin editing enzymes, such as CYLD, Otubain1, A20/TNFAIP3, the oncogene Bcl-3 and AKT. Further, we are currently investigating the role of B cells in solid tumours, such as colorectal cancer


Selected publications:
For a full publication list see: Pubmed

Hahn, M., Macht A, Waisman A, Hövelmeyer N*. (2016). NF-kappaB-inducing kinase is essential for B-cell maintenance in mice. Eur J Immunol. 10.1002/eji.201546081.
* Corresponding author

Lisak D, Schacht T, Gawlitza A, Albrecht P, Aktas O, Koop B, Gliem M, Hofstetter HH, Zanger K, Bultynck G, Parys JB, De Smedt H, Kindler T, Adams-Quack P, Hahn M, Waisman A, Reed JC, Hövelmeyer N, Methner A. (2015). Bax inhibitor-1 is a Ca(2+) channel critically important for immune cell function and survival. Cell Death Differ. 10.1038/ccd.2015.115

Reissig S*, Hövelmeyer N*, Tang Y, Weih D, Nikolaev A, Riemann M, Weih F, Waisman A. (2015). The deubiquitinating enzyme CYLD regulates the differentiation and maturation of thymic medullary epithelial cells. Immunol Cell Biol. 10.1038/icb.2014.122.
* Equal contribution

Hövelmeyer N, Wörns MA, Reissig S, Adams-Quack P, Leclaire J, Hahn M, Wörtge S, Nikolaev A, Galle PR, Waisman A. (2014). Overexpression of Bcl-3 inhibits the development of marginal zone B cells. Eur J Immunol. 10.1002/eji.201343655.
* Corresponding author

Hövelmeyer N, Reissig S, Xuan NT, Adams-Quack P, Lukas D, Nikolaev A, Schlüter D, Waisman A (2011). A20 deficiency in B cells enhances B-cell proliferation and results in the development of autoantibodies. Eur J Immunol. 10.1002/eji.201041313.
* Corresponding author

Hövelmeyer N, Wunderlich FT, Massoumi R, Jakobsen CG, Song J, Wörns MA, Merkwirth C, Kovalenko A, Aumailley M, Strand D, Brüning JC, Galle PR, Wallach D, Fässler R, Waisman A. (2007). Regulation of B cell homeostasis and activation by the tumor suppressor gene CYLD. J Exp Med.

AG Hövelmeyer

Dr. rer. nat. Hövelmeyer
Dr. rer. nat. Nadine Hövelmeyer


Petra Adams-Quack


Carina Luttenberger

+49 (0) 6131 17-9370

Romy Mittenzwei

+49 (0) 6131 17-9293

Elena Zurkowski



  •  Matthias Hahn (PhD)
  •  Eva Cox (PhD)
  • Anna Macht (Bachelor)